Lymph node immunotherapy before cervical cancer surgery
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether giving an immunotherapy drug (nivolumab) directly into lymph nodes before standard surgery can help treat cervical cancer. It is for patients who have not had prior immunotherapy treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer that has not spread beyond the cervix (stage IB3 or earlier).
- You still have your uterus and cervix.
- You are not pregnant or breastfeeding, and agree to use birth control if needed.
- You have not had immunotherapy or certain cancer treatments in the past 4 weeks.
- You do not have active infections, autoimmune diseases, or other cancers in the last 3 years.
- You can undergo MRI scans and do not have certain medical devices or conditions that would prevent it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a combination of three drugs (nab-paclitaxel, cisplatin, and sintilimab) before surgery can help treat locally advanced cervical cancer. It aims to shrink the tumor so surgery can be more effective.
This trial tests whether giving nivolumab before surgery (neoadjuvant treatment) can improve outcomes for people with certain resectable breast cancers. It focuses on tumor types linked to immune activity (like triple-negative and specific lab markers).
This trial tests if giving chemotherapy plus an immunotherapy drug before surgery can help shrink tumors and improve outcomes for patients with stage IB2 cervical cancer that has not been treated yet. It might be an option if you have a specific type of cervical cancer that shows a certain protein (PD-L1) on your tumor cells.
This trial tests whether combining two immunotherapy drugs (iparomlimab and tuvonralimab) with standard chemotherapy (paclitaxel and cisplatin) before surgery can help shrink cervical cancer. It is for people with certain stages of cervical cancer who are candidates for surgery, including those who want to preserve their fertility.
This trial tests if giving immunotherapy with chemotherapy before surgery can shrink tumors in people with advanced cervical cancer. It is for those who have not had any prior treatment.
This trial tests adding a new drug called Ivonescimab to standard chemotherapy (paclitaxel and cisplatin) given before a hysterectomy in women with cervical cancer stage IB2 or IIA1 (tumor size 2-4 cm). The goal is to see if this combination improves outcomes compared to chemo alone.
Hear when a new Cervical Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.